NYB (NYB Holdings) Inventories, Work In Process: $0.00 Mil (As of Sep. 2025)


What is NYB Holdings Inventories, Work In Process?

NYB Holdings NYB Inventories, Work In Process is $0.00 Mil as of Sep. 2025.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. NYB Holdings's work in process for the quarter that ended in Sep. 2025 was $0.00 Mil.

NYB Holdings Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for NYB Holdings's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NYB Holdings Inventories, Work In Process Chart

NYB Holdings Annual Data
Trend Sep24 Sep25
Inventories, Work In Process
0.00 0.00

NYB Holdings Semi-Annual Data
Sep24 Sep25
Inventories, Work In Process 0.00 0.00

NYB Holdings Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of $0.00 Mil mean?
NYB Holdings (NYB) has a Inventories, Work In Process of $0.00 Mil as of Sep. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on NYB Holdings and its competitors.
Is NYB Holdings' Inventories, Work In Process too high?
NYB Holdings' current Inventories, Work In Process is $0.00 Mil.
How does NYB Holdings' Inventories, Work In Process compare to ?
NYB Holdings' Inventories, Work In Process of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on NYB Holdings and its competitors. NYB Holdings's current Inventories, Work In Process is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NYB Holdings stock overvalued right now?
NYB Holdings (NYB) has a current Inventories, Work In Process of $0.00 Mil. The current Inventories, Work In Process is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For NYB Holdings (NYB), the current Inventories, Work In Process is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NYB Holdings Business Description

Comparable Companies
Address 456 Alexandra Road, No. 04-07, Fragrance Empire Building, Singapore, SGP, 119962
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.